Experience
AbbVie Inc.
Mylan Laboratories, Inc.
Represented AbbVie in ANDA litigation related to its Kaletra® products for the treatment of HIV against multiple generic drug manufacturers.
AbbVie Inc. v. Mylan Laboratories, Inc., 1:09-cv-01586, N.D. Ill., Judges Dow, Cole
AbbVie Inc. v. Mylan Laboratories, Inc., 1:15-cv-00889, 1:17-cv-01631, D. Del.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
AbbVie Inc. v. Roxane Laboratories Inc.
AbbVie Inc.
AbbVie Inc.
Tenneco Inc.
AbbVie Inc. et al v. Alvotech hf.
AbbVie Inc. et al
AbbVie Inc.
Abbott Laboratories v. Sandoz Inc.
Abbott Laboratories
Alfa Laval, Alfdex AB v. Hengst, Paccar, Inc.
Alfa Laval; Alfdex AB
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.